Asia Pacific Sarcopenia Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Treatment Type (Vitamin D and Calcium Supplement, Protein Supplement, Vitamin B12 Supplement, and Others) and Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others)

No. of Pages: 78    |    Report Code: BMIRE00030384    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Sarcopenia Treatment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Sarcopenia Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Sarcopenia Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Upsurge in Geriatric Population
  • 5.1.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
5.2 Market Opportunities
  • 5.2.1 Products in Clinical Trial Phases
5.3 Future Trends
  • 5.3.1 Rising Awareness About Sarcopenia
5.4 Impact of Drivers and Restraints

6. Asia Pacific Sarcopenia Treatment Market Regional Analysis

6.1 Asia Pacific Sarcopenia Treatment Market Overview
6.2 Asia Pacific Sarcopenia Treatment Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Sarcopenia Treatment Market Forecast Analysis

7. Asia Pacific Sarcopenia Treatment Market Analysis – by Treatment Type

7.1 Vitamin D and Calcium Supplement
  • 7.1.1 Overview
  • 7.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Protein Supplement
  • 7.2.1 Overview
  • 7.2.2 Protein Supplement: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Vitamin B12 Supplement
  • 7.3.1 Overview
  • 7.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Sarcopenia Treatment Market Analysis – by Distribution Channel

8.1 Pharmacies
  • 8.1.1 Overview
  • 8.1.2 Pharmacies: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Retail Channels
  • 8.2.1 Overview
  • 8.2.2 Retail Channels: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Online Channels
  • 8.3.1 Overview
  • 8.3.2 Online Channels: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Sarcopenia Treatment Market – Asia-Pacific Analysis

9.1 Asia-Pacific
  • 9.1.1 Asia Pacific Sarcopenia Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 9.1.1.1 Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 China: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.1.1 China: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
    • 9.1.1.1.2 China: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
  • 9.1.1.2 India: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.2.1 India: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
    • 9.1.1.2.2 India: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
  • 9.1.1.3 Japan: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.3.1 Japan: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
    • 9.1.1.3.2 Japan: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
  • 9.1.1.4 Australia: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.4.1 Australia: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
    • 9.1.1.4.2 Australia: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
  • 9.1.1.5 Rest of Asia-Pacific : Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
    • 9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Asia Pacific Sarcopenia Treatment Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Abbott Laboratories
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Bayer AG
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Metagenics LLC
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Nestle Health Science SA
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Novartis AG
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Pfizer Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Sanofi SA
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Amway Corp
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 GSK Plc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - A Market

1. Abbott Laboratories 
2. Bayer AG 
3. Metagenics LLC 
4. Nestle Health Science SA 
5. Novartis AG 
6. Pfizer Inc 
7. Sanofi SA 
8. Amway Corp 
9. GSK Plc 

asia-pacific-sarcopenia-treatment-market